Financial Advisory Partners’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-3,125
| Closed | -$290K | – | 71 |
|
2024
Q2 | $290K | Hold |
3,125
| – | – | 0.11% | 61 |
|
2024
Q1 | $297K | Hold |
3,125
| – | – | 0.11% | 59 |
|
2023
Q4 | $279K | Hold |
3,125
| – | – | 0.1% | 60 |
|
2023
Q3 | $228K | Hold |
3,125
| – | – | 0.09% | 63 |
|
2023
Q2 | $260K | Hold |
3,125
| – | – | 0.1% | 61 |
|
2023
Q1 | $238K | Hold |
3,125
| – | – | 0.09% | 63 |
|
2022
Q4 | $259K | Hold |
3,125
| – | – | 0.11% | 63 |
|
2022
Q3 | $248K | Hold |
3,125
| – | – | 0.11% | 62 |
|
2022
Q2 | $232K | Hold |
3,125
| – | – | 0.1% | 64 |
|
2022
Q1 | $281K | Hold |
3,125
| – | – | 0.1% | 64 |
|
2021
Q4 | $350K | Buy |
+3,125
| New | +$350K | 0.13% | 64 |
|